Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$51.55

0.62 (1.22%)

05:46
12/19/18
12/19
05:46
12/19/18
05:46

Bristol-Myers receives offer from Taisho to purchase UPSA for $1.6B

Bristol-Myers announced that Taisho Pharmaceutical Holdings has offered to purchase Bristol-Myers Squibb's UPSA consumer health business for $1.6B. UPSA develops and delivers important consumer medicines for patients in France, across Europe and additional countries. Taisho is the largest over-the-counter drug company in Japan, with over a century of experience in this field. Taisho holds a leading presence in anti-inflammatory analgesic, cold and flu and hair growth segments in Japan and Southeast Asia. The potential transaction is anticipated to be completed during the first half of 2019, subject to regulatory approvals and satisfaction of certain other customary closing conditions. The offer by Taisho is structured in the form of a "put option" agreement. Under the terms of the agreement, the offer is subject to Bristol-Myers Squibb's exercise of the put option following information and consultation processes with relevant employee representative bodies. Upon exercise of the put option, Bristol-Myers Squibb and Taisho would execute a definitive stock and assets purchase agreement following which Taisho would acquire all of the issued and outstanding shares of capital stock of UPSA SAS, as well as Bristol-Myers Squibb's assets and liabilities relating to the UPSA product portfolio. Assuming completion, Bristol-Myers Squibb estimates the potential transaction would be approximately (4c) dilutive to 2019 earnings.

  • 29

    Dec

  • 24

    Jan

  • 20

    May

BMY Bristol-Myers
$51.55

0.62 (1.22%)

12/11/18
GABE
12/11/18
NO CHANGE
GABE
Buy
Gabelli sees Clovis as likely takeout target, top biotech pick in 2019
Gabelli analyst Jing He highlights Clovis (CLVS) as his top biotech pick in 2019. With the Tesaro (TSRO) acquisition by GlaxoSmithKline (GSK), Clovis will become the only standalone PARP, which the analyst believes makes it the most likely takeout target in 2019. He continues to believe Bristol-Myers (BMY), Sanofi (SNY) and Roche (RHHBY) to be the most interested buyers. The analyst reiterates a Buy rating on Clovis' shares.
12/06/18
12/06/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Activision Blizzard (ATVI) upgraded to Overweight from Neutral at JPMorgan with analyst Alexia Quadrani saying the stock is down 45% from an all-time high in early October, and now trades at 16.5 times forward consensus earnings, compared to 25.5 times and 23.0 times on average over the prior one and three year periods. 2. Bristol-Myers (BMY) upgraded to Outperform from Market Perform at BMO Capital with analyst Alex Arfaei saying the risk-reward on the stock at current price "seems attractive." 3. Hostess Brands (TWNK) upgraded to Overweight from Neutral at JPMorgan analyst Ken Goldman saying by this time next year, today's two major headwinds - lost business with Walmart (WMT) and the "EBITDA-hemorrhaging" Cloverhill acquisition - will be lapped and potentially become tailwinds. 4. Spirit Airlines (SAVE) upgraded to Outperform from Neutral at with analyst Jose Caiado De Sousa saying after a "massive" Q4 unit revenue guidance boost last week, the analyst sees further upside in the equity into H1 of 2019, with expected continued momentum in non-ticket revenue production amid a lower oil environment and a benign competitive backdrop. 5. Synopsys (SNPS) upgraded to Buy from Hold at Benchmark with analyst Gary Mobley citing slightly better than expected Q4 results and in-line FY19 guidance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/06/18
JPMS
12/06/18
NO CHANGE
Target $70
JPMS
Overweight
JPMorgan still sees path to substantial Opdivo growth despite Bristol's setbacks
JPMorgan analyst Chris Schott said that investors are clearly concerned about Opdivo growth following several recent setbacks for Bristol-Myers, including mixed TMB data, pending RCC competition, and a failed SCLC study, but he still sees a path to substantial growth for the drug based on the numerous important readouts in both lung and non-lung indications coming in the next 12 months. Meanwhile, his analysis suggests Bristol-Myers' share price reflects little, if any, Opdivo growth from current levels. Given his view, and its convergence with what he believes to be the consensus view, on Opdivo, Schott sees the long term risk/reward for Bristol shares as highly attractive and keeps an Overweight rating on the stock with a $70 price target.
12/06/18
BMOC
12/06/18
UPGRADE
Target $60
BMOC
Outperform
Bristol-Myers upgraded to Outperform at BMO Capital on better Opdivo sales
As reported earlier, BMO Capital analyst Alex Arfaei upgraded Bristol-Myers to Outperform from Market Perform and raised his price target to $60 from $56, saying the risk-reward on the stock at current price "seems attractive". The analyst notes that a number of R&D setbacks have reduced expectations for the company's immuno-oncology franchise, raising his forecasts on Opdivo to reflect the "low" street consensus. Arfaei adds that the Street is modeling flattish gross margins, but his forecast calls for a 2% improvement by 2021 with Opdivo revenue expectations coming about 10%-15% above consensus. The analyst also raises his FY19 EPS view to $4.18 from $3.93 to reflect the more optimistic Opdivo targets.

TODAY'S FREE FLY STORIES

PM

Philip Morris

$79.12

0.8 (1.02%)

, HON

Honeywell

$163.86

0.2 (0.12%)

20:25
10/16/19
10/16
20:25
10/16/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PM

Philip Morris

$79.12

0.8 (1.02%)

HON

Honeywell

$163.86

0.2 (0.12%)

UNP

Union Pacific

$163.31

0.11 (0.07%)

MS

Morgan Stanley

$42.82

0.28 (0.66%)

BBT

BB&T

$53.00

0.25 (0.47%)

STI

SunTrust

$68.28

0.23 (0.34%)

PPG

PPG

$118.89

0.665 (0.56%)

MTB

M&T Bank

$159.14

0.27 (0.17%)

KEY

KeyCorp

$17.70

-0.08 (-0.45%)

GPC

Genuine Parts

$97.72

-0.22 (-0.22%)

DOV

Dover

$95.71

-0.24 (-0.25%)

TXT

Textron

$50.52

-0.15 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 04

    Nov

  • 08

    Nov

  • 10

    Nov

  • 11

    Nov

  • 12

    Nov

GLD

SPDR Gold Shares

$140.39

0.81 (0.58%)

20:11
10/16/19
10/16
20:11
10/16/19
20:11
Hot Stocks
SPDR Gold Shares holdings fall to 918.19MT from 919.66MT »

This is the second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACB

Aurora Cannabis

$3.60

-0.15 (-4.00%)

19:20
10/16/19
10/16
19:20
10/16/19
19:20
Hot Stocks
Aurora Cannabis to roll out vapes, concentrates, edibles in Canada in December »

On the one-year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

TEVA

Teva

$6.94

-0.02 (-0.29%)

19:20
10/16/19
10/16
19:20
10/16/19
19:20
Upgrade
Teva rating change at Gabelli »

Teva upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

CAAP

Corporacion America Airport

$4.39

-0.09 (-2.01%)

19:14
10/16/19
10/16
19:14
10/16/19
19:14
Hot Stocks
Corporacion America Airport reports September passenger traffic up 1.2% »

Corporacion America…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$36.65

0.38 (1.05%)

19:10
10/16/19
10/16
19:10
10/16/19
19:10
Periodicals
Tentative GM-UAW deal does not include reopening of Lordstown plant, NYP says »

A tentative agreement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

LLNW

Limelight Networks

$3.10

-0.08 (-2.52%)

, NFLX

Netflix

$286.83

2.59 (0.91%)

18:55
10/16/19
10/16
18:55
10/16/19
18:55
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

LLNW

Limelight Networks

$3.10

-0.08 (-2.52%)

NFLX

Netflix

$286.83

2.59 (0.91%)

TCBI

Texas Capital

$54.33

-0.15 (-0.28%)

CSX

CSX

$68.99

-0.18 (-0.26%)

AA

Alcoa

$19.17

-0.28 (-1.44%)

CCI

Crown Castle

$134.76

0.11 (0.08%)

RGLS

Regulus

$0.72

0.0501 (7.54%)

IBM

IBM

$142.04

-0.94 (-0.66%)

URI

United Rentals

$121.73

1.02 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 27

    Oct

  • 29

    Oct

  • 13

    Nov

NFLX

Netflix

$286.83

2.59 (0.91%)

18:37
10/16/19
10/16
18:37
10/16/19
18:37
Hot Stocks
Netflix says shares viewing data with producers each week »

Says shares viewing data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

BRBR

BellRing Brands

$0.00

(0.00%)

18:34
10/16/19
10/16
18:34
10/16/19
18:34
Syndicate
BellRing Brands 34.29M share IPO priced at $14.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

GSBC

Great Southern Bancorp

$57.28

-0.03 (-0.05%)

18:32
10/16/19
10/16
18:32
10/16/19
18:32
Earnings
Great Southern Bancorp reports Q3 preliminary EPS $1.38, consensus $1.23 »

Reports Q3 NII $45.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CRM

Salesforce

$146.96

-5.89 (-3.85%)

, FB

Facebook

$189.62

0.81 (0.43%)

18:26
10/16/19
10/16
18:26
10/16/19
18:26
Hot Stocks
Salesforce CEO: Steve Jobs had a huge impact on my life »

In an interview on…

CRM

Salesforce

$146.96

-5.89 (-3.85%)

FB

Facebook

$189.62

0.81 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 16

    Dec

NFLX

Netflix

$286.83

2.59 (0.91%)

18:19
10/16/19
10/16
18:19
10/16/19
18:19
Hot Stocks
Netflix to test mobile only plans in other markets »

Says will test mobile…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

MESO

Mesoblast

$6.04

-0.03 (-0.49%)

, LZAGY

Lonza

$0.00

(0.00%)

18:18
10/16/19
10/16
18:18
10/16/19
18:18
Hot Stocks
Mesoblast, Lonza enter into manufacture agreement of remestemcel-L in U.S. »

Mesoblast (MESO) and…

MESO

Mesoblast

$6.04

-0.03 (-0.49%)

LZAGY

Lonza

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$286.83

2.59 (0.91%)

18:12
10/16/19
10/16
18:12
10/16/19
18:12
Hot Stocks
Neflix says price increase responsible for U.S. shortfall »

Says price increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

STLD

Steel Dynamics

$28.83

-1.29 (-4.28%)

18:06
10/16/19
10/16
18:06
10/16/19
18:06
Hot Stocks
Steel Dynamics CEO says steel pricing environment 'challenging' »

"Our third quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

18:06
10/16/19
10/16
18:06
10/16/19
18:06
Hot Stocks
Netflix says price increases 'hugely' revenue positive »

Says Q3 was a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

DLPN

Dolphin Entertainment

$0.79

(0.00%)

18:05
10/16/19
10/16
18:05
10/16/19
18:05
Syndicate
Dolphin Entertainment offers to sell common stock, no amount given »

Maxim Group LLC is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLD

Steel Dynamics

$28.83

-1.29 (-4.28%)

18:03
10/16/19
10/16
18:03
10/16/19
18:03
Hot Stocks
Steel Dynamics says 'constructive' on 2020 North American steel market dynamics »

"Based on domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

STLD

Steel Dynamics

$28.83

-1.29 (-4.28%)

18:01
10/16/19
10/16
18:01
10/16/19
18:01
Earnings
Steel Dynamics reports Q3 EPS 69c, consensus 70c »

Reports Q3 revenue $2.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ISTR

Investar Holding

$23.98

0.08 (0.33%)

18:01
10/16/19
10/16
18:01
10/16/19
18:01
Hot Stocks
Investar Holding gains regulatory, holder approvals for Bank of York acquisition »

Investar Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CSX

CSX

$68.99

-0.18 (-0.26%)

17:57
10/16/19
10/16
17:57
10/16/19
17:57
Hot Stocks
CSX reverses in after-hours, trading up over 4% »

Shares of CSX are now up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 13

    Nov

EGO

Eldorado Gold

$7.40

0.175 (2.42%)

17:50
10/16/19
10/16
17:50
10/16/19
17:50
Hot Stocks
Eldorado Gold reports Q3 preliminary gold production of 101,596 oz. »

Eldorado Gold reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

BHP

BHP Group

$48.17

-0.51 (-1.05%)

17:38
10/16/19
10/16
17:38
10/16/19
17:38
Hot Stocks
BHP Group backs FY20 iron ore output view of 242-253 MT »

Backs FY20 petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

PEGI

Pattern Energy

$26.14

-0.26 (-0.98%)

17:37
10/16/19
10/16
17:37
10/16/19
17:37
Downgrade
Pattern Energy rating change at Goldman Sachs »

Pattern Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

BHP

BHP Group

$48.17

-0.51 (-1.05%)

17:35
10/16/19
10/16
17:35
10/16/19
17:35
Hot Stocks
BHP Group reports Q1 iron ore output 61MT, down 1% from last year »

Reports Q1 petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.